Where can I find the specific financial figures and performance data?

The specific financial figures and performance data are not included directly in the 8-K filing itself. Investors need to refer to the press release dated February 2, 2003, which is attached as Exhibit 99 to this report.

What are the key risks Anthem identifies that could affect its future performance?

Anthem identifies several key risks, including fluctuating healthcare costs and utilization rates, the ability to secure adequate premium rate increases, competitive pricing pressures, increased government regulation, challenges in integrating acquisitions like Trigon Healthcare, Inc., and general economic downturns.

Does this filing provide updated guidance for future financial performance?

The filing references 'forward-looking information' and 'financial projections and estimates' within the press release. However, it also contains strong cautionary statements that actual results may differ materially due to various risks. Investors should review the referenced press release and other SEC filings for any specific forward-looking guidance and understand the associated risks.

ELV 8-K SEC Disclosure

Q: What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to report Anthem, Inc.'s (now Elevance Health, Inc.) financial results for the fourth quarter and full year ended December 31, 2002. These results are detailed in a press release included as Exhibit 99 to this filing.

Summary

This 8-K filing from Anthem, Inc. (now Elevance Health, Inc.) on February 3, 2003, primarily serves to report the company's financial results for the fourth quarter and full year ended December 31, 2002, via a press release filed as Exhibit 99. The filing does not contain specific financial figures within the 8-K itself but directs investors to the attached press release for detailed performance metrics and forward-looking statements. Investors should pay close attention to the accompanying press release for information regarding Anthem's financial health, operational performance, and future outlook as of early 2003. The report also includes important cautionary language regarding forward-looking statements, as mandated by the Private Securities Litigation Reform Act of 1995. Anthem emphasizes that actual results could differ materially from projections due to various risks and uncertainties inherent in the health care industry. These include, but are not limited to, trends in healthcare costs, regulatory changes, competitive pressures, acquisition integration (specifically Trigon Healthcare, Inc.), and general economic conditions. Investors are encouraged to review Anthem's other SEC filings for a comprehensive understanding of these risks.

Key Highlights

1Anthem, Inc. (now Elevance Health, Inc.) filed an 8-K on February 3, 2003, to report Q4 and full-year 2002 financial results.
2The detailed financial results are contained within a press release dated February 2, 2003, filed as Exhibit 99.
3The filing includes standard safe harbor disclosures for forward-looking statements under the Private Securities Litigation Reform Act of 1995.
4Anthem outlines potential risks and uncertainties that could impact future financial performance.
5Key risk factors mentioned include healthcare cost and utilization trends, premium rate increases, competitor pricing, government regulation, and acquisition integration (Trigon Healthcare).
6Investors are directed to review other Anthem SEC filings, including Form S-3 and prior 10-K/10-Q reports, for further risk disclosures.
7The report was signed by Michael L. Smith, Executive Vice President and Chief Financial and Accounting Officer.

Elevance Health, Inc. 8-K Report (Feb 4, 2003)

Summary

Key Highlights

Frequently Asked Questions